Type 2 & other diabetes

Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study

J Clin Endocrinol MetabPublished Population-based cohort study

Authors' conclusion

While liver-related mortality rates decreased significantly among patients with diabetes, NVNA causes made up the majority of cases. Excess mortality for liver-related causes in patients with diabetes compared with controls remained constant in the studied period.

Study context

Population
General population of Lombardy, Italy (about 16%, almost 10 million, of Italy's population), 2010–2019
Exposure
People with diabetes vs without diabetes
Outcome
Time trends in cause-specific liver-related mortality (viral, alcohol related, NVNA)
Follow-up
2010 to 2019
Methodological detailshealth care utilization databases, time-trend analysis 2010–2019
  • Health care utilization databases
  • Time-trend analysis 2010–2019

Main finding

As reported in the abstract

Liver-related mortality, people with diabetes
Crude liver disease mortality rate in diabetes, 2010 to 2019
1.13 to 0.64 deaths per 1000 person-years
NVNA share of liver-related deaths, 2010 to 2019
63% to 68%
Viral share of liver-related deaths, 2010 to 2019
27% to 23%
SMR in diabetes, NVNA
3.35 (95% CI 2.96-3.76)
SMR in diabetes, viral hepatitis
1.66 (95% CI 1.33-2.01)
SMR in diabetes, alcoholic liver disease
1.61 (95% CI 1.13-2.17)

Observational data: associations, not effects.

Further findings

Share of deaths due to liver diseases · 2019

Excess mortality risk in diabetes: liver-related vs CVD and cancer

Excess liver-related mortality risk in diabetes was higher than for CVD mortality and cancer

Original publication

Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study. J Clin Endocrinol Metab. Published 20 March 2024. doi:10.1210/clinem/dgae182

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.